CPhI Japan 2020

วันที่ 30 กันยายน 2563 - 2 ตุลาคม 2563

ณ Intex Osaka Exhibition Centre

     One of the most critical issues affecting the expansion of Japan’s generic drug sector is the lack of a stable API supply. More than 50% of Japan’s APIs are imported into the country for generic drugs manufacturing with its main international suppliers being Korea, China, India and European countries (Spain, Germany, Italy, Hungary etc). With the Japanese government looking to grow the generic drugs sector the demand for APIs is set to rise and the country will continue to search further for supplier options.

Event Contact